BACKGROUND: We explore vaccination strategies against pandemic influenza in Mexico using an age-structured transmission model calibrated against local epidemiological data from the Spring 2009 A(H1N1) pandemic. METHODS AND FINDINGS: In the context of limited vaccine supplies, we evaluate age-targeted allocation strategies that either prioritize youngest children and persons over 65 years of age, as for seasonal influenza, or adaptively prioritize age groups based on the age patterns of hospitalization and death monitored in real-time during the early stages of the pandemic. Overall the adaptive vaccination strategy outperformed the seasonal influenza vaccination allocation strategy for a wide range of disease and vaccine coverage parameters. CONCLUSIONS: This modeling approach could inform policies for Mexico and other countries with similar demographic features and vaccine resources issues, with regard to the mitigation of the S-OIV pandemic. We also discuss logistical issues associated with the implementation of adaptive vaccination strategies in the context of past and future influenza pandemics.
BACKGROUND: We explore vaccination strategies against pandemic influenza in Mexico using an age-structured transmission model calibrated against local epidemiological data from the Spring 2009 A(H1N1) pandemic. METHODS AND FINDINGS: In the context of limited vaccine supplies, we evaluate age-targeted allocation strategies that either prioritize youngest children and persons over 65 years of age, as for seasonal influenza, or adaptively prioritize age groups based on the age patterns of hospitalization and death monitored in real-time during the early stages of the pandemic. Overall the adaptive vaccination strategy outperformed the seasonal influenza vaccination allocation strategy for a wide range of disease and vaccine coverage parameters. CONCLUSIONS: This modeling approach could inform policies for Mexico and other countries with similar demographic features and vaccine resources issues, with regard to the mitigation of the S-OIV pandemic. We also discuss logistical issues associated with the implementation of adaptive vaccination strategies in the context of past and future influenza pandemics.
Authors: Mark A Miller; Cecile Viboud; Donald R Olson; Rebecca F Grais; Maia A Rabaa; Lone Simonsen Journal: J Infect Dis Date: 2008-08-01 Impact factor: 5.226
Authors: Hans P Duerr; Stefan O Brockmann; Isolde Piechotowski; Markus Schwehm; Martin Eichner Journal: BMC Infect Dis Date: 2007-07-13 Impact factor: 3.090
Authors: Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds Journal: PLoS Med Date: 2008-03-25 Impact factor: 11.069
Authors: Eli P Fenichel; Carlos Castillo-Chavez; M G Ceddia; Gerardo Chowell; Paula A Gonzalez Parra; Graham J Hickling; Garth Holloway; Richard Horan; Benjamin Morin; Charles Perrings; Michael Springborn; Leticia Velazquez; Cristina Villalobos Journal: Proc Natl Acad Sci U S A Date: 2011-03-28 Impact factor: 11.205
Authors: José M Aguilar-Yáñez; Roberto Portillo-Lara; Gonzalo I Mendoza-Ochoa; Sergio A García-Echauri; Felipe López-Pacheco; David Bulnes-Abundis; Johari Salgado-Gallegos; Itzel M Lara-Mayorga; Yenny Webb-Vargas; Felipe O León-Angel; Ramón E Rivero-Aranda; Yuriana Oropeza-Almazán; Guillermo M Ruiz-Palacios; Manuel I Zertuche-Guerra; Rebecca M DuBois; Stephen W White; Stacey Schultz-Cherry; Charles J Russell; Mario M Alvarez Journal: PLoS One Date: 2010-07-22 Impact factor: 3.240
Authors: Marc Pearton; Sang-Moo Kang; Jae-Min Song; Alexander V Anstey; Matthew Ivory; Richard W Compans; James C Birchall Journal: PLoS One Date: 2010-08-25 Impact factor: 3.240